Vicarious Surgical (NYSE:RBOT) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Vicarious Surgical (NYSE:RBOT) from a sell rating to a hold rating in a research note issued to investors on Saturday.

A number of other research firms also recently weighed in on RBOT. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Vicarious Surgical in a report on Wednesday, October 8th. BTIG Research reaffirmed a “neutral” rating on shares of Vicarious Surgical in a research note on Friday, December 12th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $7.00.

Vicarious Surgical Price Performance

Shares of Vicarious Surgical stock opened at $2.64 on Friday. Vicarious Surgical has a 52-week low of $1.80 and a 52-week high of $16.92. The firm has a market capitalization of $17.29 million, a PE ratio of -0.29 and a beta of 1.52. The company’s fifty day moving average price is $2.89 and its two-hundred day moving average price is $5.71.

Vicarious Surgical (NYSE:RBOT) last issued its earnings results on Wednesday, November 12th. The company reported ($1.91) earnings per share for the quarter, beating the consensus estimate of ($2.37) by $0.46. Analysts predict that Vicarious Surgical will post -10.89 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Vicarious Surgical

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP grew its stake in shares of Vicarious Surgical by 22.1% during the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after purchasing an additional 3,615 shares during the last quarter. Connective Capital Management LLC bought a new position in Vicarious Surgical in the 3rd quarter worth approximately $169,000. Finally, DNB Asset Management AS lifted its holdings in Vicarious Surgical by 12.1% during the 2nd quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock worth $219,000 after buying an additional 3,154 shares in the last quarter. Institutional investors and hedge funds own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.